Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Randomized, Active-Controlled Comparison of the Immunogenicity and Safety of Flublok® Quadrivalent Versus IIV4 in Healthy, Medically Stable Adults 18-49 Years of Age

NCT02290509 is registered in ClinicalTrials.gov with Protein Sciences Corporation as lead sponsor.

NCT NCT02290509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02290509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Randomized, Active-Controlled Comparison of the Immunogenicity and Safety of Flublok® Quadrivalent Versus IIV4 in Healthy, Medically Stable Adults 18-49 Years of Age
Lead sponsor
Protein Sciences Corporation
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2014
Completion date
May 31, 2015
Enrollment
1,350 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

influenza